biotechnology | Science and Enterprise

Vietnam War Memorial #flickr https://t.co/VwB3z4ZQrF ... photo from #MemorialDay 2010 ... @jaketapper
about 5 hours ago
A therapy program for depression designed to reduce spirals of repeated negative thinking is licensed to a digital… https://t.co/Op6EDZgwpS
about 12 hours ago
New post on Science and Enterprise: Depression Therapy Licensed for Online Distribution https://t.co/pKWAsbbhAu #Science #Business
about 12 hours ago
The Federal Reserve, the U.S. central bank, released statistics showing in April 2020, manufacturing output dropped… https://t.co/q390P26pNf
about 3 days ago
New post on Science and Enterprise: Infographic – Largest Ever U.S. Manufacturing Decline https://t.co/WkZSpIfnoj #Science #Business
about 3 days ago

Stem Cell Therapy Licensed for Genetic Eye Disease

By Alan, on May 8th, 2020%

A biotechnology company is licensing its stem cell treatments for retinitis pigmentosa, an inherited eye disease, in a deal valued at $252 million. . . . → Read More: Stem Cell Therapy Licensed for Genetic Eye Disease

Vaccine Blocks Suspected Type 1 Diabetes Infections

By Alan, on May 7th, 2020%

A candidate vaccine is shown in lab animals to produce a strong immune response against a virus causing a range of diseases, and possibly blocking type 1 diabetes. . . . → Read More: Vaccine Blocks Suspected Type 1 Diabetes Infections

Synthetic Antibody Limits M.S. Inflammation

By Alan, on May 6th, 2020%

An artificial antibody is shown in lab mice to reduce inflammation similar to multiple sclerosis in the brain and activate myelin cells in the spinal cord. . . . → Read More: Synthetic Antibody Limits M.S. Inflammation

[Updated] Fast Paper Strip Covid-19 Test Devised with Crispr

By Alan, on May 6th, 2020%

A simple, fast test for Covid-19 infections with treated paper dipped in specimens is being created with the gene-editing technology Crispr. . . . → Read More: [Updated] Fast Paper Strip Covid-19 Test Devised with Crispr

Microsoft, Biotech Examine Covid-19 Immune Response

By Alan, on May 5th, 2020%

A study is enrolling home-bound participants to learn more about the response of T-cells in the immune system to SARS-CoV-2 viruses causing Covid-19 infections. . . . → Read More: Microsoft, Biotech Examine Covid-19 Immune Response

Biotech Gains Antibody Discovery, Manufacturing Funds

By Alan, on May 4th, 2020%

A Canadian biotechnology company is receiving government funds for Covid-19 antibody discovery and manufacturing for current and future pandemics. . . . → Read More: Biotech Gains Antibody Discovery, Manufacturing Funds

Oxford, AstraZeneca Partner on Covid-19 Vaccine

By Alan, on April 30th, 2020%

AstraZeneca agreed today to help develop, manufacture, and distribute a candidate vaccine to prevent Covid-19 infections designed by University of Oxford. . . . → Read More: Oxford, AstraZeneca Partner on Covid-19 Vaccine

Limited Covid-19 Benefits Found for Arthritis Drug

By Alan, on April 27th, 2020%

A clinical trial testing an arthritis drug to treat Covid-19 patients shows the drug helps the most critical patients, but not others with advanced infections. . . . → Read More: Limited Covid-19 Benefits Found for Arthritis Drug

Trial Okayed in Germany for Covid-19 Vaccine

By Alan, on April 23rd, 2020%

Regulators in Germany cleared a clinical trial to begin testing a vaccine with synthetic RNA to prevent coronaviruses from causing Covid-19 infections. . . . → Read More: Trial Okayed in Germany for Covid-19 Vaccine

Fast, Simple Covid-19 Antibody Test Being Developed

By Alan, on April 20th, 2020%

An engineering lab is creating an easy-to-use test of immune-system antibodies to the SARS-Cov-2 virus responsible for Covid-19 infections. . . . → Read More: Fast, Simple Covid-19 Antibody Test Being Developed

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise